EN
登录

Luminary Labs授予BARDA合同,启动Project NextGen疫苗创新奖竞赛

Luminary Labs awarded BARDA contract to launch Project NextGen vaccine innovation prize competitions

CISION 等信源发布 2023-10-13 23:24

可切换为仅中文


$100 million, five-year initiative targets improved vaccine technologies through prize competitions.

1亿美元的五年计划目标是通过奖品比赛改进疫苗技术。

NEW YORK, Oct. 13, 2023 /PRNewswire/ -- Luminary Labs, a leader in accelerating innovation on behalf of the public, private, and nonprofit sectors, today announced its partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S.

纽约,2023年10月13日/PRNewswire/-Luminary Labs,代表公共,私营和非营利部门加速创新的领导者,今天宣布与生物医学高级研究与发展局(BARDA)合作,部分美国战略准备和响应管理局。

Department of Health and Human Services. Luminary Labs will design, promote, and administer two prize competitions in support of Project NextGen's goal to accelerate the development of COVID-19 vaccines, therapeutics, and enabling technologies..

卫生与公共服务部。Luminary Labs将设计,推广和管理两奖比赛,以支持NextGen项目加速开发COVID-19疫苗,治疗和支持技术的目标。。

The two international prize competitions will focus on:

这两项国际奖赛将重点关注:

Catalyzing the development of patch-based vaccine delivery technologies with an emphasis on the collection of clinical evidence with a path toward regulatory approval and commercialization. The prize competition is expected to launch in 2024, with up to $50 million in prizes.

催化基于补丁的疫苗递送技术的发展,重点是收集临床证据,为监管批准和商业化开辟道路。奖品竞赛预计于2024年推出,奖品最高可达5000万美元。

Reducing the number of doses needed to achieve an effective immune response against a novel coronavirus or pandemic influenza. Current vaccination strategies for novel viruses typically require two doses for full protection. The prize competition is expected to launch in 2026, with up to $41 million in prizes..

减少实现针对新型冠状病毒或大流行性流感的有效免疫应答所需的剂量数量。目前针对新型病毒的疫苗接种策略通常需要两剂才能完全保护。奖品竞赛预计于2026年推出,奖品最高可达4100万美元。。

'As the COVID-19 pandemic transitions out of an emergency phase, there is an opportunity to assess alternative vaccine technologies for improved pandemic responses in the future,' said Luminary Labs CEO Sara Holoubek. 'We are honored to partner with BARDA to reimagine vaccine delivery technology and help our nation prepare for known and unknown threats.'.

Luminary Labs首席执行官Sara Holoubek说:“随着新型冠状病毒肺炎大流行从紧急阶段过渡过来,有机会评估未来改善大流行应对的替代疫苗技术我们很荣幸与BARDA合作,重新设计疫苗输送技术,帮助我们的国家为已知和未知的威胁做好准备。

In addition to providing strategy and innovation consulting services to the private and nonprofit sectors, Luminary Labs has more than a decade of experience designing and producing large-scale open innovation programs that have helped federal agencies, corporations, and foundations accelerate effective, scalable solutions.

除了为私营和非营利部门提供战略和创新咨询服务外,Luminary Labs还有十多年的设计和生产大规模开放式创新计划的经验,帮助联邦机构,公司和基金会加速有效,可扩展的解决方案。

Through a contract with NASA, Luminary Labs has designed and produced prize competitions on behalf of the National Geospatial-Intelligence Agency, the National Institutes of Health, the U.S. Coast Guard, the U.S. Department of Health and Human Services, and the U.S. Department of Homeland Security. Through separate contact vehicles, the company has provided similar services to the U.S.

通过与NASA的合同,Luminary Labs代表国家地理空间情报局,美国国立卫生研究院,美国海岸警卫队,美国卫生与公众服务部和美国国土安全部设计并制作了奖品比赛。通过单独的联系方式,公司向美国提供了类似的服务。

Department of Education, the U.S. Department of Veterans Affairs, and the U.S. Food and Drug Administration. Engagements across Luminary Labs' future of health portfolio have helped life sciences and health clients rethink what's possible by identifying where business priorities, emerging technologies, and customer needs meet..

教育部,美国退伍军人事务部和美国食品和药物管理局。Luminary Labs未来健康组合的参与帮助生命科学和健康客户通过确定业务优先事项,新兴技术和客户需求满足的位置来重新思考可能发生的事情。。

This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under OT number 75A50123C00059.

该项目全部或部分由美国卫生与公众服务部的联邦资金资助;管理战略准备和响应;生物医学高级研究与开发局,编号75A50123C00059。

About Luminary LabsLuminary Labs is a New York City-based strategy and innovation consultancy established in 2009. The company's work covers a broad cross section of topics across four focus areas — the future of work and education, the future of health, scientific discovery, and infrastructure — on behalf of Fortune 500, government, and nonprofit clients.

关于Luminary LabsLuminary实验室是2009年成立的纽约市战略和创新咨询公司。该公司的工作涵盖了四个重点领域的广泛主题-工作和教育的未来,健康的未来,科学发现和基础设施-代表“财富”500,政府和非营利客户。

Luminary Labs is a certified woman-owned small business..

Luminary Labs是一家拥有认证女性的小企业。。

Media contact[email protected]

媒体联系[电子邮件保护]

SOURCE Luminary Labs

源照明实验室